Provident Financial Services, Inc. Logo
Provident Financial Services, Inc. Reports Second Quarter 2024 Results Inclusive of Merger-Related Costs and Declares Quarterly Cash Dividend
July 25, 2024 17:25 ET | Provident Financial Services, Inc.
ISELIN, N.J., July 25, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported a net loss of $11.5 million, or $0.11 per basic and diluted share for the three...
Eagle Bancorp, Inc.
Eagle Bancorp, Inc. Announces Second Quarter 2024 Results
July 24, 2024 16:15 ET | Eagle Bancorp, Inc.
BETHESDA, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (NASDAQ: EGBN), ("Eagle", "the Company", "we", "us", "our"), the Bethesda-based parent company of EagleBank (the "Bank"),...
Alterity.png
Alterity Therapeutics to Present at MST Financial Webinar
July 24, 2024 07:35 ET | ALTERITY THERAPEUTICS LIMITED
MELBOURNE, Australia and SAN FRANCISCO, July 24, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
ROIC_ NEW logo_blue text transparent background.png
Retail Opportunity Investments Corp. Reports 2024 Second Quarter Results
July 23, 2024 16:15 ET | Retail Opportunity Investments Corp.
SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three and six months ended June 30, 2024. ...
Arbutus Biopharma Logo
Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
July 18, 2024 07:30 ET | Arbutus Biopharma Corporation
WARMINSTER, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Agios_2021_Logo.png
Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024
July 18, 2024 07:00 ET | Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
TriumphFinancial_Logo_FullColor.png
Triumph Financial Releases Second Quarter 2024 Financial Results
July 17, 2024 16:07 ET | Triumph Financial, Inc.
DALLAS, July 17, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its second quarter 2024 financial results. The 2Q 2024 financial results and shareholder letter are...
MYR Group logo
MYR Group Inc. Announces Second-Quarter 2024 Earnings Release and Conference Call Schedule
July 17, 2024 16:05 ET | MYR Group, Inc.
THORNTON, Colo., July 17, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure,...
bitfarms.jpg
Bitfarms’ Newly Appointed CEO to Participate Today in a Fireside Chat Hosted by H.C. Wainwright
July 17, 2024 07:00 ET | Bitfarms Ltd.
TORONTO, Ontario and BROSSARD, Québec, July 17, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global vertically integrated Bitcoin data center company, announces its...
Eagle Bancorp Announ
Eagle Bancorp Announces Earnings Call on July 25, 2024
July 10, 2024 06:00 ET | Eagle Bancorp, Inc.
BETHESDA, Md., July 10, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the parent company of EagleBank, today announced that it will host a teleconference call for the...